Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Tyndall

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
Current Rheumatology Reports|July 22, 2008
Cellular therapy of systemic sclerosisJacob M van Laar, Alan Tyndall
Therapeutische Umschau. Revue Therapeutique|January 8, 2014
[Biologics and infections in rheumatic diseases]Thomas Hügle, Thomas Daikeler, Alan Tyndall
Presse Medicale (Paris, France : 1983)|June 4, 2016
Stem cell transplantation and mesenchymal cells to treat autoimmune diseasesAlan Tyndall, Jacob M van Laar
Cancer Control : Journal of the Moffitt Cancer Center|February 25, 2003
Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a reviewJacob M Van Laar, Alan Tyndall
Annals of the Rheumatic Diseases|April 26, 2019
Barbara Ansell: a person ahead of her timePat Woo, Nico M Wulffraat, Alan Tyndall
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United StatesKeith M Sullivan, Paolo Muraro, Alan Tyndall
JAMA|November 5, 2014
Cardiac assessment before stem cell transplantation for systemic sclerosis--replyJacob M van Laar, Dominique Farge, Alan Tyndall
Drugs|May 10, 2007
Scleroderma lung: pathogenesis, evaluation and current therapyJacob M van Laar, Jan Stolk, Alan Tyndall
Rheumatology (Oxford, England)|May 9, 2015
Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosisJacob M van Laar, Kamran Naraghi, Alan Tyndall
Current Opinion in Rheumatology|October 24, 2008
The EULAR Scleroderma Trials and Research Group (EUSTAR): an international framework for accelerating scleroderma researchAlan Tyndall, Ulf M Ladner, Marco Matucci-Cerinic
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Current Rheumatology Reports|July 22, 2008
Cellular therapy of systemic sclerosisJacob M van Laar, Alan Tyndall
Therapeutische Umschau. Revue Therapeutique|January 8, 2014
[Biologics and infections in rheumatic diseases]Thomas Hügle, Thomas Daikeler, Alan Tyndall
Presse Medicale (Paris, France : 1983)|June 4, 2016
Stem cell transplantation and mesenchymal cells to treat autoimmune diseasesAlan Tyndall, Jacob M van Laar
Cancer Control : Journal of the Moffitt Cancer Center|February 25, 2003
Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a reviewJacob M Van Laar, Alan Tyndall
Annals of the Rheumatic Diseases|April 26, 2019
Barbara Ansell: a person ahead of her timePat Woo, Nico M Wulffraat, Alan Tyndall
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United StatesKeith M Sullivan, Paolo Muraro, Alan Tyndall
JAMA|November 5, 2014
Cardiac assessment before stem cell transplantation for systemic sclerosis--replyJacob M van Laar, Dominique Farge, Alan Tyndall
Drugs|May 10, 2007
Scleroderma lung: pathogenesis, evaluation and current therapyJacob M van Laar, Jan Stolk, Alan Tyndall
Rheumatology (Oxford, England)|May 9, 2015
Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosisJacob M van Laar, Kamran Naraghi, Alan Tyndall
Current Opinion in Rheumatology|October 24, 2008
The EULAR Scleroderma Trials and Research Group (EUSTAR): an international framework for accelerating scleroderma researchAlan Tyndall, Ulf M Ladner, Marco Matucci-Cerinic
Pageof 11